Search results for: 'point pharmaceutical'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

This research service analyzes the market for point-of-care testing within the United States. The market is divided into 13 segments and covers testing performed by healthcare professionals in the physician office lab, hospital, clinics, and patient self-testing environments. Each segment covers the market overview, competitive structure, market s...

The study analyses the current and future trends of the pumps market in the European pharmaceutical industry. With a number of end-user markets affected due to recession, this study determines the impact of recession on this market. Analysis by each product type have been discussed and analysed. In addition, trends by applications are also included...

This research service analyses the European ophthalmic pharmaceuticals market. The base year is 2009 with forecasts running through 2016. The segments covered include: the European Glaucoma pharmaceuticals market, European AMD pharmaceuticals market , European Allergic Conjunctivitis pharmaceuticals market , European Diabetic Retinopathy pharmac...

This study covers the water and wastewater treatment market in pharmaceutical industries. Storage systems have been excluded, while piping and other turnkey solutions have been included in the scope of this study.

For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

This research service provides a thorough analysis of various aspects of the healthcare industry in Russia and some CIS countries (Ukraine, Kazakhstan, Belarus). Originally, the research provides the insight of the impact of socio-economic and political factors on the development of the healthcare industry. After that, the major developments in the...